Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
FDA Clears New Heart Disease Risk Test for Clinical Labs
The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories.
Flow Cytometry
Latest
ARUP Laboratories Launches Spectral Flow Cytometry Test for Multiple Myeloma Monitoring
The assay is designed to detect minimal residual disease with greater sensitivity than conventional flow cytometry.
Mass Spectrometry
Latest
University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer
The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.
Immunoassay
Latest
NanoSomiX and Beckman Coulter Partner to Develop Blood Tests for Brain Diseases
NanoSomiX and Beckman Coulter Diagnostics have partnered to develop automated blood-based immunoassays for detecting neurodegenerative disease biomarkers, aiming to enable scalable testing in clinical and research laboratories.
Molecular Diagnostics
Latest
Cepheid Introduces Third-Generation GeneXpert Molecular Testing System
Cepheid will debut its third-generation GeneXpert molecular testing system at ADLM 2024, featuring a touchscreen interface, updated software, and continued support for FDA-cleared tests and existing laboratory workflows.
Point-of-Care
Latest
Roche Receives FDA Clearance for Point-of-Care Bordetella Test
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.